Acute lymphoblastic leukaemia: open trials in Brazil

10 open trials have a site in Brazil. Registry data; only the trial team decides who can take part.

NCT05959720
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil
Research · Instituto do Cancer do Estado de São Paulo
Instituto do Câncer do Estado de São Paulo, São Paulo
Registry updated 2026-11-03
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Fundação Pio XII - Hospital de Câncer de Barretos (Site 1264), Barretos · Hospital Erasto Gaertner-CEPEP - Pesquisa Clínica (Site 1268), Curitiba · Hospital de Clinicas de Porto Alegre (Site 1265), Porto Alegre · Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa (Site 1267), São José do Rio Preto
Registry updated 2026-10-30
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 1/2 · AstraZeneca
Porto Alegre · São Paulo
Registry updated 2026-10-13
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Rio de Janeiro · São Paulo
Registry updated 2026-07-06
NCT05705570
Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies
Trial Treatment · Phase 1 · Nelson Hamerschlak
Hospital Israelita Albert Einstein, São Paulo
Registry updated 2025-09-25
NCT05929976
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Research · Columbia University
Hospital de Cancer Infanto Juvenil de Barretos, Barretos · Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife · Instituto de Tratamento do Câncer Infantil (ITACI), São Paulo
Registry updated 2025-07-22
NCT05541341
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
Research · Novartis Pharmaceuticals
Curitiba · Minas Gerais · Salvador · São Paulo
Registry updated 2025-06-06
NCT06034561
Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Trial Treatment · Phase 2 · Instituto do Cancer do Estado de São Paulo
Instituto do Câncer do Estado de São Paulo, São Paulo
Registry updated 2025-05-16
NCT06299462
PTCy and ATG for MSD and MUD Transplants
Trial Treatment · Phase 1/2 · Instituto Nacional de Cancer, Brazil
Instituto Nacional de Câncer, Rio de Janeiro
Registry updated 2025-02-25
NCT06101381
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
Trial Treatment · Phase 1/2 · University of Sao Paulo
Hospital de Clínicas da UNICAMP, Campinas · Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirão Preto · Hospital Sirio Libanes, São Paulo · Hospital das Clinicas de São Paulo, São Paulo · A Beneficência Portuguesa de São Paulo, São Paulo
Registry updated 2024-12-09

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error